1. Show article details.

    Mylan stock drops after Abbott files to sell about one-third of its stake

    MarketWatch – 8:38 AM ET 03/30/2015

    Shares of Mylan NV (MYL) slumped 5% in premarket trade Monday, after the drug maker said it began a public offering of 35 million shares of its common stock held by Abbott Laboratories (ABT). That represents 32% of the 110 million Mylan shares owned by Abbott as of Feb. 27, according to FactSet. Mylan said Abbott is also granting the underwriters of the offering an option to buy an additional 5.25 million shares.

  2. Show article details.

    Abbott Labs Files to Sell Nearly a Third of Its Mylan Stake

    DJ Business News – 8:23 AM ET 03/30/2015

    Abbott Laboratories (ABT) filed to offer nearly a third of its stake in Mylan NV (MYL) that it got from the recent sale of a portion of its generic-drugs business to the Netherlands-based drug maker. The companies in July said Mylan would buy Abbott's drug portfolio in developed overseas markets, in a $5.3 billion deal that would allow Mylan to benefit from a lower tax rate by organizing the new company in the Netherlands. Under a revised deal, Abbott received a stake of about 22% in the new Mylan.

  3. Show article details.

    Mylan N.V. Announces Commencement of Secondary Public Offering of a Portion of Abbott's Ordinary Shares

    PR Newswire – 6:30 AM ET 03/30/2015

    POTTERS BAR, England, March 30, 2015 Mylan N.V. (MYL) today announced the underwritten public offering of 35,000,000 ordinary shares held by certain subsidiaries of Abbott Laboratories. Morgan Stanley & Co. LLC and Goldman, Sachs & Co. are acting as joint book-running managers for the Offering.

  4. Show article details.

    Mylan N.V. and Mylan Inc. Announce Successful Completion of Consent Solicitations for Mylan Inc.'s Notes

    PR Newswire – 12:30 PM ET 03/12/2015

    POTTERS BAR, England and PITTSBURGH, March 12, 2015Mylan N.V. (MYL) and Mylan Inc. today announced the successful completion of the previously announced consent solicitations relating to Mylan's 3.750% Cash Convertible Notes due 2015, 7.875% Senior Notes due 2020, 3.125% Senior Notes due 2023, 1.800% Senior Notes due 2016, 2.600% Senior Notes due 2018, 1.350% Notes due 2016, 2.550% Notes due 2019, 4....

  5. Show article details.

    Shake Shack, Box shares drop after earnings

    MarketWatch – 5:56 PM ET 03/11/2015

    By Wallace Witkowski and Sue Chang, MarketWatch. Bank stocks mostly higher after Fed capital plan review. SAN FRANCISCO-- Shares of Shake Shack Inc. (SHAK) and Box Inc. (BOX), both of which started publicly trading in January, dropped in the extended session Wednesday after quarterly results fell short of Wall Street estimates.

  6. Show article details.

    Mylan Launches Generic Subutex® Sublingual Tablets

    PR Newswire – 7:30 AM ET 03/11/2015

    POTTERS BAR, England and PITTSBURGH, March 11, 2015 Mylan N.V. (MYL) and Mylan Inc. today announced the U.S. launch of Buprenorphine Hydrochloride Sublingual Tablets, 2 mg and 8 mg, which is the generic version of Reckitt Benckiser's Subutex® Sublingual Tablets.

  7. Show article details.

    Mylan Launches Generic Antabuse® Tablets

    PR Newswire – 7:00 AM ET 03/11/2015

    POTTERS BAR, England and PITTSBURGH, March 11, 2015Mylan N.V. (MYL) and Mylan Inc. today announced the U.S. launch of Disulfiram Tablets USP, 250 mg and 500 mg, which is the generic version of Odyssey Pharmaceutical's Antabuse®. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product, which is an aid in the management of selec...

  8. Show article details.

    Mylan Launches First and Only Available Intermediate Dosage Strengths of Fentanyl Transdermal System 37.5, 62.5 and 87.5 mcg/hr

    PR Newswire – 6:30 AM ET 03/11/2015

    POTTERS BAR, England and PITTSBURGH, March 11, 2015 Mylan N.V. (MYL) and Mylan Inc. today announced the U.S. launch of its Fentanyl Transdermal System 37.5, 62.5 and 87.5 mcg/hr, adding to its existing offering of Fentanyl Transdermal System 12, 25, 50, 75 and 100 mcg/hr.

  9. Show article details.

    Mylan to Present at the Barclays Global Healthcare Conference

    PR Newswire – 8:00 AM ET 03/06/2015

    POTTERS BAR, England and PITTSBURGH, March 6, 2015 Mylan N.V. (MYL) today announced that the Company will present at the Barclays Global Healthcare Conference on Wednesday, March 11, 2015. The presentation is scheduled to begin at 8:30 a.m. ET. Interested parties can access a live webcast of the presentation via the investor relations section of Mylan's Web site at http://mylan.com/investors.

  10. Show article details.

    Kindred Names Jon B. Rousseau Executive Vice President and President of RehabCare

    Business Wire – 4:30 PM ET 03/05/2015

    Kindred Healthcare, Inc. (KND) today announced that Jon B. Rousseau, President of Kindred’s Care Management Division, has been named Executive Vice President and President of RehabCare, effective with the April 1, 2015 retirement of Patricia M. Henry. Kindred also today announced the appointment of Christopher Day as Senior Vice President, Strategy and Care Management.

  11. Show article details.

    Smith & Wesson shares shoot up after earnings beat, outlook

    MarketWatch – 5:08 PM ET 03/03/2015

    By Wallace Witkowski and Sue Chang, MarketWatch. TiVo (TIVO) shares also rally on subscription growth. SAN FRANCISCO-- Shares of Smith& Wesson Holding Co. rallied in the extended session Tuesday after the gun maker's quarterly earnings and outlook topped Wall Street estimates.

  12. Show article details.

    MARKET SNAPSHOT: U.S. Stocks Retreat From Records; Car Sales Sputter

    DJ Business News – 4:36 PM ET 03/03/2015

    By Anora Mahmudova and Victor Reklaitis, MarketWatch. Monthly car sales slow to 10- month low in February. NEW YORK-- U.S. stocks declined on Tuesday, retreating from all-time highs and the psychologically significant 5,000 level for the Nasdaq reached on Monday.

  13. Show article details.

    U.S. stocks retreat from records; car sales sputter

    MarketWatch – 4:35 PM ET 03/03/2015

    By Anora Mahmudova and Victor Reklaitis, MarketWatch. Monthly car sales slow to 10- month low in February. NEW YORK-- U.S. stocks declined on Tuesday, retreating from all-time highs and the psychologically significant 5,000 level for the Nasdaq reached on Monday.

  14. Show article details.

    US STOCKS-Wall St falls from records, led by technology stocks

    Reuters – 4:33 PM ET 03/03/2015

    * Auto sales fall short of expectations. * Netanyahu warns Obama against Iran deal. * Technology stocks fall after Nasdaq milestone. * Indexes off: Dow 0.47 pct, S&P 0.45 pct, Nasdaq 0.56 pct. By Sinead Carew. U.S. stocks finished down on Tuesday, a day after the S&P and Dow hit records, and the Nasdaq retreated with technology stocks.

  15. Show article details.

    US STOCKS-Wall St falls from latest records after soft auto sales

    Reuters – 2:36 PM ET 03/03/2015

    * Auto sales fall short of expectations. * Netanyahu warns Obama against Iran deal. * Technology stocks fall after Nasdaq milestone. * Indexes off: Dow 0.45 pct, S&P 0.48 pct, Nasdaq 0.64 pct. By Sinead Carew. U.S. stocks fell on Tuesday, a day after S&P and Dow hit records and Nasdaq retreated after hitting a 15-year milestone after soft car sales data and Iran commentary worried some investors.

  16. Show article details.

    US STOCKS-Wall St falls from latest records; auto sales soft

    Reuters – 11:42 AM ET 03/03/2015

    * Auto sales fall short of expectations. * Best Buy (BBY) climbs after results. * Citigroup (C) to sell OneMain Financial to Springleaf Holdings (LEAF). * Indexes off: Dow 0.7 pct, S&P 0.8 pct, Nasdaq 0.9 pct. By Chuck Mikolajczak. U.S. stocks fell on Tuesday, as the Dow and S&P retreated from their latest records and the Nasdaq dipped below 5,000 after scaling the milestone level for the first time in 15 years.

  17. Show article details.

    US STOCKS-Wall St slips from latest records; Nasdaq below 5,000

    Reuters – 9:58 AM ET 03/03/2015

    * Auto sales fall short of expectations. * Best Buy (BBY) climbs after results. * Citigroup (C) to sell OneMain Financial to Springleaf Holdings (LEAF). * Indexes off: Dow 0.35 pct, S&P 0.41 pct, Nasdaq 0.44 pct. By Chuck Mikolajczak. U.S. stocks edged lower shortly after the open on Tuesday in the wake of the latest records for the Dow and S&P and the Nasdaq scaling the 5,000 mark for the first time in 15 years.

  18. Show article details.

    REFILE-US STOCKS-Wall St to dip at open after latest records, Nasdaq 5,000

    Reuters – 9:00 AM ET 03/03/2015

    * Auto sales expected throughout session. * Best Buy (BBY) climbs in premarket after results. * Citigroup (C) to sell OneMain Financial to Springleaf Holdings (LEAF). * Futures off: Dow 38 pts, S&P 5.75 pts, Nasdaq 9.25 pts. By Chuck Mikolajczak.

  19. Show article details.

    Mylan N.V. and Mylan Inc. Announce Commencement of Consent Solicitations for Mylan Inc.'s Notes

    PR Newswire – 8:55 AM ET 03/03/2015

    POTTERS BAR, England, and PITTSBURGH, March 3, 2015 Mylan N.V. (MYL) and Mylan Inc. today announced the commencement of consent solicitations relating to Mylan's 3.750% Cash Convertible Notes due 2015, 7.875% Senior Notes due 2020, 3.125% Senior Notes due 2023, 1.800% Senior Notes due 2016, 2.600% Senior Notes due 2018, 1.350% Senior Notes due 2016, 2.550% Senior Notes due 2019, 4.200% Senior Notes d...

  20. Show article details.

    Mylan still on the prowl for deals, perhaps one by end 2015

    Reuters – 7:23 PM ET 03/02/2015

    U.S. generic drug maker Mylan Inc (MYL) is still on the prowl for more deals, after completing the multibillion-dollar acquisition of some of Abbott Laboratories' (ABT) non-U.S. businesses just last week. Chief Executive Heather Bresch, on a call after the company posted fourth-quarter results on Monday, raised the prospect of another "material transaction" by the end of 2015.

Page:

Today's and Upcoming Events

  • Apr
    30

    MYL to announce Q1 earnings Before Market (Unconfirmed)

Past Events (last 90 days)

No events in the past 90 days

Data provided by Wall Street Horizon, Inc. © 2015

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.